Hib conjugate vaccine (Chengdu Olymvax Biopharmaceuticals)

bๅž‹ๆตๆ„Ÿๅ—œ่ก€ๆ†่Œ็ป“ๅˆ็–ซ่‹—๏ผˆๆˆ้ƒฝๆฌงๆž—็”Ÿ็‰ฉ็ง‘ๆŠ€๏ผ‰

Report date: 2022/10/18 16:43:22

Base Information

Drug NameHib conjugate vaccine (Chengdu Olymvax Biopharmaceuticals)
Drug Alias Namebๅž‹ๆตๆ„Ÿๅ—œ่ก€ๆ†่Œ็ป“ๅˆ็–ซ่‹— - ๆˆ้ƒฝๆฌงๆž—็”Ÿ็‰ฉ็ง‘ๆŠ€Haemophilus influenzae type b conjugate vaccine (Chengdu Olymvax Biopharmaceuticals)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4]ย 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisArthritisCellulitis +[7]ย 
Global Approved IndicationsHaemophilus Infections
Approved Indications in ChinaHaemophilus Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2017/05/18
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChengdu Oulin Biological Science & Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Oulin Biological Science & Technology Co Ltd
Inactive CompaniesJiangsu Provincial Center For Disease Control And Prevention
Active IndicationsHaemophilus Infections
Inactive IndicationsMeningitisArthritisCellulitis +[6]ย 

Other Information

ATC CodeJ07AG01
Related LinksN/A